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Background: The incidence of chronic diseases, including diabetes mellitus (DM), heart failure (HF) and chronic
obstructive pulmonary disease (COPD) is on the rise. The existing health care system must evolve to meet the
growing needs of patients with these chronic diseases and reduce the strain on both acute care and hospital-based
health care resources. Paramedics are an allied health care resource consisting of highly-trained practitioners who
are comfortable working independently and in collaboration with other resources in the out-of-hospital setting.
Expanding the paramedic’s scope of practice to include community-based care may decrease the utilization of
acute care and hospital-based health care resources by patients with chronic disease.
Methods/Design: This will be a pragmatic, randomized controlled trial comparing a community paramedic
intervention to standard of care for patients with one of three chronic diseases. The objective of the trial is to
determine whether community paramedics conducting regular home visits, including health assessments and
evidence-based treatments, in partnership with primary care physicians and other community based resources, will
decrease the rate of hospitalization and emergency department use for patients with DM, HF and COPD. The primary
outcome measure will be the rate of hospitalization at one year. Secondary outcomes will include measures of health
system utilization, overall health status, and cost-effectiveness of the intervention over the same time period. Outcome
measures will be assessed using both Poisson regression and negative binomial regression analyses to assess the
primary outcome.
Discussion: The results of this study will be used to inform decisions around the implementation of community
paramedic programs. If successful in preventing hospitalizations, it has the ability to be scaled up to other regions,
both nationally and internationally. The methods described in this paper will serve as a basis for future work
related to this study.
Trial registration: ClinicalTrials.gov: NCT02034045. Date: 9 January 2014.
Keywords: Randomized controlled trial, Community health services, Primary health care, Allied health personnel* Correspondence: DrennanI@smh.ca
†Equal contributors
1Rescu, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 30 Bond St,
Toronto, ON M5B 1W8, Canada
2Institute of Medical Science, Faculty of Medicine, University of Toronto,
Toronto, ON, Canada
Full list of author information is available at the end of the article
© 2014 Drennan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Drennan et al. Trials 2014, 15:473 Page 2 of 10
http://www.trialsjournal.com/content/15/1/473Background
Patients with chronic diseases have high rates of health
care utilization and are currently costing the health care
system billions of dollars each year [1-3]. In order to ef-
fectively care for the increasing number of individuals
living with chronic disease, there has emerged a need for
novel community-based health initiatives. Individuals with
diabetes mellitus (DM) are over 3 times more likely to be
hospitalized with cardiovascular disease than individuals
without diabetes, 12 times more likely to be hospitalized
with end-stage renal disease, and almost 20 times more
likely to be hospitalized with non-traumatic lower limb
amputations [4]. There are 5.5 million people in the
United States and Canada living with heart failure (HF)
with 850,000 new patients diagnosed annually [5,6] and
more than 900,000 hospitalizations a year are attributable
to HF [6-8]. Chronic obstructive pulmonary disease
(COPD) is one of the fastest growing chronic diseases;
it is the third leading cause of death in the United
States [9] and fourth leading cause of death in Canada,
[10] and has an average hospitalization of 10 days for
an exacerbation with an associated cost of $10,000
[11]. The existing health care system, which primarily
revolves around hospital-based care and primary care
providers, must evolve to incorporate new strategies of
delivering care to better meet the needs of this growing
population, resulting in improved patient care and more
efficient resource utilization.
To this end, the addition of community paramedics may
enrich the system that currently manages these patients.
Paramedics are a highly-trained group of prehospital prac-
titioners certified in both basic and advanced life support
care who work under the medical delegation of base hos-
pital physicians. Paramedics are mobile, community-based
practitioners accessible 24 hours a day, who are efficient
and effective in managing emergencies and providing
comprehensive care in the out-of-hospital environment
[12]. Paramedics are the first, and sometimes only, point
of contact for many in the community for disease-related
exacerbations/symptomatology. They are able to identify
subtle signs of potentially life-threatening issues, and
provide comprehensive care as per medical directives or
reach out to on-call physicians to address issues at the
bedside before they become emergencies.
The integration of community paramedics into health
care models has attracted international attention. Studies
in the United Kingdom, Australia and the United States
have shown that community paramedic implementation
is feasible, safe and effective while at the same time im-
proving satisfaction of patients and practitioners and
minimizing health care costs [13]. Despite this, there has
been minimal adoption of community paramedic pro-
grams in Canada. While the evidence supporting commu-
nity paramedicine is promising a comprehensive systematicreview identified only a single randomized controlled trial
(RCT) from the United Kingdom that evaluated the effi-
cacy of community paramedics [14]. By combining in-
home visits by community paramedics with physician
oversight and integration with existing community re-
sources, the Expanding Paramedicine in the Community
(EPIC) study will provide an innovative chronic care model
in order to maximize patient care by allotting available re-
sources in a tiered delivery system.
We propose to perform a randomized controlled trial
to answer the following question: does expanding para-
medic scope of practice to include chronic disease man-
agement, characterized by home visits to facilitate the
assessment and treatment of patients under the medical
delegation of the primary care physician, reduce the rate
of acute care hospitalization?Methods/Design
This stratified, randomized controlled trial will examine
the effectiveness of a community paramedicine interven-
tion in reducing hospital admission among family health
team patients diagnosed with either COPD, HF or DM.
We consider our trial to be pragmatic [15] for the follow-
ing reasons: (1) the patient populations will be broad, tar-
geting patients at high-risk, with few exclusion criteria; (2)
the intervention will be implemented in a ‘usual’ practice
setting; (3) the intervention will be flexible, and may be
adapted according to identified needs over the study
period; (4) the outcomes are patient-centered; and (5)
the trial results will be of interest to decision-makers
[15,16]. The trial has received research ethics board
approval from St. Michael’s Hospital and Markham
Stouffville Hospital (Research Ethics Board # 13-086).
See Additional files 1 and 2.Setting
The regional municipality of York is a geographically di-
verse region in southern Ontario with a mix of rural and
suburban centers and a population of just over 1 million
residents. York Region Emergency Medical Services (EMS)
is the sole provider of 911 medical services in York Region
with both primary care paramedics and advanced care
paramedics who are certified through the Ministry of
Health and Long-Term Care (MOHLTC). They operate
under the medical oversight of physicians from a single
base hospital (Central East Prehospital Care Program) and
are employed to provide medical care and transportation
services within the region.
Patients for this study will be recruited from the
Markham Family Health Team and the Health For All
Family Health Team, the two largest family health
teams in York Region, each with over 5,000 subscribing
adult patients.
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Patients of the participating family health teams diag-
nosed with either HF, COPD or DM will be screened for
potential study eligibility by their primary care physician
by applying search filters to the patients’ electronic med-
ical records (EMR). Eligibility criteria are listed in Table 1.
Patients will be deemed to be high-risk at the discretion of
the primary care physician, based on (i) prior patterns of
health care use, (ii) test results, (iii) compliance and (iv)
clinical gestalt. Enrolled patients will be confirmed to be
high-risk for admission by determining their rates of hos-
pital admission over the 3 years prior to study enrollment,
through linkage with the Institute for Clinical Evaluative
Sciences (ICES) databases. Rates of admission will then
be compared to previous literature to determine patients
who are high-risk.
Recruitment and randomization
Eligible patients will be contacted by their family phys-
ician and given multiple opportunities to provide their
consent to participate. Enrollment will employ a modi-
fied Dillman method [17] with prepaid postage response
cards. All patients will be consented using exactly the
same process prior to randomization. See Additional files 3
and 4.
A block stratified randomization procedure will be used
to randomize eligible, consenting patients to treatment or
control groups (1:1 ratio). Randomization will occur using
a computer generated randomized number sequence allo-
cated by block based on disease, using variable block sizes
to avoid substantial imbalances in the number of patients
assigned to each group (Figure 1) and to ensure the three
disease groups are represented in the intervention or con-
trol (usual care) group. Stratification will balance differ-
ences in disease characteristics, which may influence the
primary outcomes. Should patients have multiple diagno-
ses, patients with HF will be categorized HF regardless of
the other diagnoses and patients with both COPD and
DM will be categorized as COPD. Categorization is based
on the prevalence of disease previously noted in a subset
of patients in which the number of patients diagnosed as
having HF was markedly reduced. A preliminary feasibilityTable 1 Study eligibility criteria
Eligibility criteria Ineligibi
Patients are eligible if: Patients
• They are residents of the region of York • They
• They are 18 years of age or older • They
lang
com
indiv
be a
• They have been diagnosed (at any point in time prior to
enrollment) with, and currently receiving treatment for COPD,
HF, or DM
• They are identified by the Family Health Care Team as being
at high-risk for hospital admissionsample of cases from within the two family health care
teams identified 548 patients: 74 COPD patients, 417 DM
patients, and 31 HF patients. One patient had all 3 condi-
tions, 17 had diabetes and HF, 1 had HF and COPD and
finally 7 patients had both diabetes and COPD. Informed
consent will be obtained from all patients prior to enroll-
ment in the EPIC study. Patient recruitment will occur
over a 1-year period. Based upon the preliminary feasibility
sample and the sample size calculation required to detect a
15% difference in our primary outcome, this will be suffi-
cient time to enroll the required number of patients.
Planned treatment groups
The intervention will consist of an initial visit and 3
follow-up visits at 3-month intervals by a paramedic
who has received additional training in chronic disease
management. The specially designed training consists
of a 6-week in-class education program designed and pro-
vided by Centennial College in Toronto, Ontario, Canada,
expanding the paramedic’s scope of care for this patient
population and non-emergency practice. This curriculum
will include didactic, clinical (that is specialized disease spe-
cific clinics), skills and immersive simulation/case-based
instruction. The didactic portion will include the following
courses: Health Assessment, Diagnostics and Care (theory
and hands-on practice), Pathophysiology, Pharmacology
and Health Teaching and Promotion. Core competencies
target foundational knowledge, communication, assessment
and diagnostics, therapeutics including pharmacology,
integration, and health promotion. Clinical placements
under the direct supervision of specialists or physicians
along with simulation-based practice will occur concur-
rently to flexibly engage students in relevant cases to
promote application of concepts, skill development,
clinical reasoning and transfer. A total of seven commu-
nity paramedics have been trained. This will be a suffi-
cient number of paramedics to carry out the planned
patient visits for the intended sample size, as well as
additional time set aside for visits initiated outside of
the planned visits. This is based on a total number of
168 hours per week (7 am to 7 pm, 5 days a week) dur-
ing which 1 of 2 community paramedics are availablelity criteria
are ineligible if:
are residents of long-term care facilities
have cognitive impairment, uncontrolled psychiatric disease or
uage barriers that would make it difficult to understand the consent and
municate with the paramedic during the scheduled visits, unless the
idual with power of attorney for personal care consented and agreed to
t each visit
Figure 1 Patient block stratified randomization procedure.
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dardized baseline number of visits by the community
paramedics and will occur in addition to routine usual
care and any additional health care visits prompted by the
patient, the paramedic or the family health care team. The
initial visit and each follow-up visit by the community
paramedic will include a medical history and physical
examination based on disease-specific elements recorded
on an electronic assessment tool that is e-linked to the pa-
tient care record for the entire family health care team.
Patients will receive disease-specific education and coun-
seling in accordance with the community paramedic med-
ical directives. If necessary, the community paramedic may
initiate treatment in the home, based on disease-specific
evidence-based medical directives and/or may initiate tele-
phone contact with the primary health care physician in
accordance with their medical directive. If treatment is ini-
tiated by community paramedics, patients are expected
to follow up with their family physician within 72 hours.
Additional primary care physician and/or community
paramedic follow-up appointments may be scheduled
by the paramedic as required. Community Care Access
Center (CCAC) and other community resources will also
be notified at the discretion of the primary care physicians
or other family health care team members. The patient
will be able to notify their family health team or the com-
munity paramedic about the need for a subsequent assess-
ment based on any change in their condition.
Patients randomized to the control group will continue
to receive usual care from their family health care team.
Usual care includes physician assessment and treatment
and periodic augmentation of care in the community
(CCAC case manager or nurse practitioner) at the discre-
tion of the treating physician.
Considerations to reduce bias
Due to the intended treatment plan it is not possible to
blind paramedics, clinicians or research personnel totreatment assignment. To help minimize selection bias,
randomization will occur via a computer-generated ran-
dom number formulation. Detection bias will be minimized
through linkage to copies of province-wide administrative
datasets held at ICES. Ascertainment bias will be controlled
by using objective clinical outcomes that are not under
the control of the paramedic or the family health care
team (for example, hospital admission, length of stay,
death). Attrition bias is avoided as we are using health
outcomes that are routinely measured and housed as
administrative data points, and using a primary intention-
to-treat (ITT) analysis will minimize the potential bias
due to patient withdrawal, dropout or study protocol vi-
olations. Contamination bias will be reduced as eligible
patients from the same family will be assigned to the
first family member’s randomly assigned treatment group.
Missing data will be minimized through point of care logic
and error checks, built-in data management reports run
weekly and timely oversight by study staff; however, any
remaining missing data will be dealt with using multiple
imputation. The statistical measures of our data manage-
ment system are published [18]; there is > 90% agreement
in the variables of interest common to all cases with mod-
erate or excellent kappa (0.65 to 0.87).
Proposed primary and secondary outcome measures
The primary outcome of this trial is the number of hospi-
talizations per patient after one year of study enrollment.
Secondary outcomes will be measures of health system
utilization at 1-year (reported as all cause and disease spe-
cific) and will include the following:
1. Calls to 911 (regardless of whether patient was
transported to hospital)
2. Visits to the participating family health team clinics
and any after-hours clinics
3. Length of stay in hospital if admitted
4. Mortality
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(Euroqol-5D 3L) EQ-5D-3L measured at baseline
and one year after study enrollment [19,20]
6. Measures of intervention compliance and safety
(that is completed assessments and visits and protocol
violations identified by physician review of EMR)
7. Cost-effectiveness analysis for this model of care
The family health team electronic patient record data
will be linked via the health card number to province-
wide administrative health datasets held at the ICES, a
section 45 Prescribed Entity under Ontario’s Personal
Health Information Protection Act. Health services data
at ICES represent ‘transactions’ of health care utilization,
such as inpatient/outpatient hospital utilization, emer-
gency room and other ambulatory clinic visits, drug
claims for patients 65 and older, claims for physician
services in any setting, and others. Linkage to the ICES
administrative databases requires use of the Ontario
health card number for each subject; following linkage,
only the unique ICES encrypted identifier will remain
on the files used for analysis. Linkage will allow us to
obtain a more comprehensive view of specific health
system utilization than could be achieved with unlinked
data. Many disease-specific codes have been validated in
ICES’ databases [21-23].
Patients will be asked about health-related quality of life
using the EQ-5D-3 L, [20] a validated measure of quality-
adjusted life years (QALY). QALY, a preference-based util-
ity measure, incorporates both length of life and quality of
life into a single measure. To estimate QALYs, we will
convert EQ-5D data collected in the study to utility score
using a validated algorithm [19] so no additional data col-
lection will be required. Health-related quality of life as-
sessments will be performed at baseline and 1-year after
study enrollment. Assessments will be performed by the
community paramedics for patients enrolled in the inter-
vention cohort and by the patients’ primary care physi-
cians in the control cohort.
Sample size
The proposed sample size is based on yearly hospitalization
rates in Ontario of 296/100,000 for HF, [24] 632/100,000
for COPD [25] and 67/100,000 for DM [26] and 1-year
mortality rates of 10% for HF, [27] 4.4% for COPD [28]
and 8.2% for DM [29]. A Poisson regression with a sample
of 695 (348 per group) achieves 80% power at a 0.05 sig-
nificance level to detect a response rate ratio of at least
0.85 between groups (intervention and control) given a
baseline rate of 1.85 and an assumed phi (over-dispersion
parameter) of 1.0. The sample size was adjusted since a
multiple regression of the covariate of interest on the
other covariates in the Poisson regression is expected to
have an R-squared of 0.05. We believe this to be sufficientpower to detect a clinically relevant improvement of 15%
in hospital admission rates. The proposed sample size cal-
culation will be confirmed by using the baseline rates of
admission as determined through ICES for patients en-
rolled in the EPIC study.
Data collection and management
I. Confidentiality and security
Data regarding patient assessment and treatment is
currently collected in the family health team’s EMR and
is remotely accessed by health care providers (physicians,
social workers, dieticians, physician assistants and nurse
practitioners). CCAC and the community paramedics will
be joining the patients’ circle of care and will sign confi-
dentiality agreements to be provided with EMR access.
II. Data abstraction
Trained data abstractors will enter data from patients’
hospital visits into the EMR. They will be trained by the
study staff and complete all the necessary privacy and
confidentiality paperwork prior to beginning data ab-
straction. Patient data will be collected at each encoun-
ter with the community paramedic, both scheduled and
unscheduled. Data from the paramedic reports and fam-
ily health team EMRs will be abstracted and manually
entered into the database housed at St. Michael’s Hos-
pital on a continual basis throughout the study in real
time. Outcome data (that is emergency department (ED)
visits, hospital admissions, calls to 911) will be collected
at study completion for each patient.
III. Data entry and data storage
All study data and clinical variables collected in the
EMR will be stored on St. Michael’s Hospital research
data servers. This server site is in compliance with Per-
sonal Health Information Privacy Act (PHIPA) guide-
lines. This password protected database has restricted
access in compliance with the privacy and ethical practices
of St. Michael’s Hospital. Access to the room, which con-
tains the research file server, is restricted to designated
persons who are employed by St. Michael’s Hospital. The
database is stored electronically on this file server that is
protected by a firewall, and making it inaccessible exter-
nally. Safeguards are in place to protect personal health
information against loss, theft, as well as unauthorized
access, disclosure, copying, use, or modification. The
nature of the safeguards will vary depending on the for-
mat of the information, and the method of storage. Only
co-investigators will have access to the final trial dataset
on a request basis via the primary investigator.
IV. Privacy considerations for study intervention
Protecting the privacy of the subjects whose health infor-
mation is obtained and housed by our research program is
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studies and is of utmost importance. This commitment is
demonstrated through the adherence to and the compli-
ance with Canada’s federal privacy law, the Personal Infor-
mation Protection and Electronic Documents Act 2000
(PIPEDA - current to 24 March 2011), the Ontario privacy
legislation, and PHIPA 2004 (last amendment: 2010).
Data analysis
Clinical trials involving community-based medicine and
prehospital providers are conducted in relatively uncon-
trolled environments. These settings can be unpredict-
able and pose many unique operational and analytical
challenges for even the most rigorously designed clinical
trials such as loss of patient follow-up and problems
with data capture. To accommodate such challenges in a
manner that maintains applicability to usual clinical
practice yet ensures scientific integrity, study outcomes
will be evaluated in two populations: an ITT or ‘safety
population’ as our primary analysis and a modified
intention-to-treat (MITT) or ‘efficacy population’ as a
sensitivity analysis.
Outcome analyses
The MITT or efficacy population will consist of all eli-
gible randomized patients who met all eligibility criteria
and who received the full study protocol (4 scheduled
paramedic visits over a 1-year period or patients ran-
domized to the control group who remained in the study
for the full 1-year period). Furthermore, this trial is
intended to target patients with chronic disease who are
at high-risk for admission to hospital. However, initial
patient enrollment into the study was based upon family
physician estimation of patient risk; therefore there is a
possibility that some patients enrolled in the study do
not represent a high-risk group for hospital admission.
Patients enrolled in the trial will have their risk of ad-
mission assessed based on their actual rates of admission
over the previous 3 years. This information will be gath-
ered through linkage with the ICES databases. Cut-off
values for low, medium and high-risk categories will be
calculated based on a review of the literature and clinical
expertise. Only those patients who are determined to be
high-risk will be included in the MITT analysis. Con-
versely, the ITT or effectiveness population includes all
patients randomized regardless of their eligibility, adher-
ence to study protocol or calculated risk of admission.
The primary analysis will be done using an ITT analysis.
Baseline characteristics of patients in the intervention and
control groups within each disease-specific group will be
reported using descriptive statistics, mean/SD or median/
IQR for continuous variables and count/percent for
categorical as appropriate. Tests of significance will be
performed using t-tests or Wilcoxon rank-sum test forcontinuous variables and chi-square or Fisher’s exact
test (expected counts < 5) for categorical variables as
appropriate. Two-sided P-value < 0.05 will be used to de-
termine significant differences in baseline characteristics.
These analyses are useful not only to assess the compar-
ability of the treatment group but also to describe the
sample of subjects who entered the trial. Test of normality
for each variable will be determined using the Shapiro-
Wilk test P-value < 0.05. All tests will be two-sided and
carried out at a significance level at 5%.
The primary outcome, number of hospital admissions
over 1 year will be compared by group using both Poisson
regression and negative binomial regression analyses. The
goodness of fit of both models will be evaluated using
Akaike’s information criterion (AIC) statistics. If, in spite
of randomization, differences in baseline characteristics
are found using bivariate analytical strategies, these vari-
ables will be included in the regression model. Multiple
imputation algorithms will be developed in order to deter-
mine values for any missing data points [30].
The secondary outcome measures, which are largely
count measures, will be compared between control and
intervention groups using similar Poisson regression and
negative binomial models. The proportion of patients
who die during the study period will be compared for
the intervention and control groups within each disease-
specific group using chi-square tests as well as a logistic
regression model, adjusting for any potential confounding
variables as appropriate.
Economic analysis
Subsequent to the outcome analysis, we will conduct an
economic analysis. The objective of the economic ana-
lysis will be to compare the relative costs and effects of
a community paramedicine intervention with usual
care. We will conduct the analysis from the perspective
of the MOHLTC using data from the randomized con-
trolled trial and ICES. Since the effectiveness outcomes
are hospitalization, ED visits, primary care visits, EMS
utilization and medication use, which can be expressed
in monetary terms (for example, hospitalization cost),
we will convert the outcomes to dollars and will analyze
the costs of the two groups. Total cost for each patient
includes the cost of intervention and the health care
costs incurred within 1-year following randomization
(as defined in the outcome measures sections). Based on
initial intervention assignment, we will analyze the cost
variable as a dependent variable to estimate the difference
in expected health care cost with a study group as the pri-
mary independent variable in a regression model. Employ-
ing regression will allow for the adjustment of potential
confounders (for example, patient characteristics).
In theory, an ordinary least squares (OLS) model pro-
duces unbiased estimates even if the data are skewed;
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generalized linear models [32]) and different uncertainty
methods (for example, parametric and non-parametric
confidence intervals) will facilitate careful investigation of
the impact various assumptions have on our conclusions.
In addition, we will conduct a cost-effectiveness analysis
using mortality and QALY as the outcome of interest.
Methods for censored cost and outcome data will be ac-
commodated in a net benefit regression framework [33,34].
Subgroup analyses
We will conduct subgroup analyses to determine whether
any of the following factors modify the effect of commu-
nity paramedic interventions on study outcomes: family
health team allocation, socioeconomic status, living alone,
immigrant status, age, gender, distance from clinic and
home care utilization.
An interim safety analysis will be conducted after 6
months from the last primary assessment of the first
50% enrolled using data from family health team EMRs
and paramedic ePCRs. Interim analysis will be con-
ducted to evaluate the intervention for issues relating to
patient safety predefined as community paramedic non-
compliance with specified protocols and physician inter-
ventions post-paramedic assessment.
Knowledge translation and dissemination of results
There will be a fully integrated knowledge translation (KT)
and dissemination approach over the course of the study
with involvement from a number of community and gov-
ernment stakeholders. During the evaluation we will have
regular project feedback presentations open to all stake-
holders (patients, family health teams, paramedics, EMS
services, CCAC, MOHLTC) with summaries circulated to
all participating organizations. We will have a regular pro-
ject newsletter to share implementation information and
interim findings and organize stakeholder conferences
with the intervention team and our MOHLTC partners
to keep the lines of communication open regarding the
community paramedicine approach.
We will use traditional end-of-grant KT strategies
(for example, presentations, publications, press releases,
social media strategies including animated shorts, and so
on) to share lessons from EPIC as well as to disseminate
its results. We will present findings at national and inter-
national academic research conferences to a wide range of
audiences to ensure that we target the broad range of dis-
ciplines involved in this study.
Discussion
While the evidence supporting community paramedicine
is promising, there has yet to be a convincing trial evaluat-
ing the impact of community paramedicine on the health
outcomes of, and health system utilization costs associatedwith, chronic disease patients. EPIC employs a chronic
care model that integrates with the current health care
system, and has the potential to positively impact health
outcomes for individuals living with DM, COPD and HF.
Chronic care models of care delivery are integrated disease
management plans consisting of self-management support,
clinical decision support, a unified clinical information
system, and organization of health care and community
resources [35]. Disease management plans with two or
more components of care have been shown to shorten
hospital length of stay as well as decrease rates of hospi-
talizations and ED visits [35]. The most effective disease
management plan enables the adjustment of treatment
[36] through high-frequency patient contact and case
management [37]. Using a regional, community-based
strategy, the EPIC study will implement such a disease
management plan in order to reduce rates of hospital
admission and emergency department visits for those liv-
ing with at least one of the three most common chronic
diseases: DM, HF and COPD.
We believe that the EPIC intervention has the potential
to significantly impact the management of chronic health
disease, via reduced hospitalizations and ED visits, which
in turn reflects quality of care [38]. Our intervention is de-
signed to work within the existing health care system to
maximize the quality of care it delivers as well as the use
of existing resources. The simplicity of the intervention
means that, if proven useful, community paramedicine
could easily be scaled up to other EMS services and
community health care teams and expanded to cover a
broader range of health conditions and populations of
individuals.
Paramedics are an under-utilized resource, well suited
to provide community-based health care to patients in
their homes. They are highly-trained health care practi-
tioners who are mobile in the community and have the
infrastructure in place to provide home care services; how-
ever, they are limited in some communities to responding
to 911 emergency calls. They have a unique skill set, are
able to use their surroundings to capture information,
identify subtle signs of potentially life-threatening issues,
and provide comprehensive care as per medical directives
or through conversation with on-call physicians to address
issues at the bedside before they become emergencies.
Paramedics are ideally suited to provide integrated care
above and beyond current community resources to provide
care for patients with chronic disease. Given that they
work under the medical delegation of base hospital physi-
cians, paramedics have the ability to provide active treat-
ment that other health care providers, such as nurses
working in the homecare setting, cannot. In communities
with low population density, paramedics have the potential
to expand their scope of practice and provide care during
predictable low volume time intervals. In addition, current
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to 20% of the paramedic workforce is on modified duty
and unable to manage the heavy lifting required for emer-
gency call responses [39]. This group could be refocused
on community paramedicine booked appointments, while
other physically fit colleagues maintain current EMS per-
formance standards [39]. Extending a paramedic’s current
knowledge of chronic disease to include routine care and
prevention of morbidity and mortality will require a mod-
est investment in education; however, there are anticipated
future year cost avoidance benefits. Current projections an-
ticipate the need to increase EMS staff by at least 50% over
the next 10 years [39] to address the shift to an aging
population; this could be mitigated in part by community
paramedicine programs as part of an integrated system.
Despite the many theoretical advantages and the anec-
dotal evidence there is a lack of quality research evaluating
the effects of community paramedicine programs on pa-
tient care and safety, health care systems and economic
impact. In Nova Scotia, a longitudinal mixed-methods
study was undertaken that utilized a nurse practitioner-
paramedic-family physician care model [40]. Community
paramedics performed diabetic assessments, wound care,
congestive heart failure assessments, drew blood for sub-
sequent lab tests, and provided education sessions. Be-
tween year 1 (pre-intervention) and year 3 (year following
implementation of intervention), there was a 40% decrease
in ED visits, 28% decrease in family physician visits and a
marked decrease in mean total health costs [40]. A recent
systematic review [13] identified only one randomized
controlled trial from the United Kingdom that evaluated
the effectiveness of community paramedics [14]. Although
this study identified benefits to the use of community
paramedic practitioners in the UK it was limited by meth-
odological flaws including; quasi-randomization proce-
dures, a significant proportion of patients who did not
receive the treatment they were assigned, and poor re-
sponse to the survey questionnaire [14]. In the interests
of economic efficiency, it is imperative that studies be
undertaken to properly evaluate the role of community
paramedics before these programs undergo widespread
implementation. Furthermore, the study will measure
the reduction of burden placed on the existing health
system, both in time and cost, by delivering quality pa-
tient care at the non-acute level.
Like any pragmatic randomized trial implemented in a
real-world setting, we anticipate there will be a few chal-
lenges in conducting this study. There are some threats
to follow-up such as the inability to complete the sched-
uled paramedic visits and the possibility of missing out-
come data. The community paramedics will be responsible
for setting appointments and ensuring that the patients
have adequate notification. The paramedics will travel to
the patient’s home for the appointment, which by designwill minimize the risk of missed appointments; however
patients could go on extended holidays, move away or se-
lect to discontinue in the study, which would affect the
ability to complete the intervention. The resulting inability
to measure outcomes in these patients will be minimized
by using datasets linked by a universal health insurance
number documented by the paramedic at the level of the
patient as well as several source documents. We have a
track record of diligence in data capture and outcome
measurement; our current randomized trials of prehospital
interventions have < 1% missingness for benchmarked crit-
ical variables and loss to follow-up for primary and sec-
ondary outcomes [41,42]. A modest threat of selection and
ascertainment bias exists regardless of the strategies we
have described previously to try to minimize this risk of
bias.
If found to be effective, this pragmatic intervention is
designed such that it could be implemented in many ju-
risdictions, which would extend the benefits of the inter-
vention to many more patients living with these chronic
diseases. It is expected that our study will be able to pro-
vide rigorous answers regarding the utility of the inter-
vention in improving health outcomes for patients with
chronic diseases.
Trial status
In order to test feasibility of the intervention process, as
well as ease of patient recruitment, a pilot study of the
EPIC protocol has been underway since March 2013. To
date, the EPIC team has recruited 22 physicians from 2
family health teams and 6 paramedics from York Region
EMS. Each physician has reviewed and signed off on the
medical directives and processes have been created and
tested to enable online physician consultation during the
EPIC visits, as well as physician review of documentation
and intervention post visit. A search of the family health
team’s EMR dataset using the study inclusion criteria
identified an initial list of potential patients, which was
then reviewed by the physicians. A preliminary sample
of eligible cases identified 548 patients, and we consented
and randomized 210 (38.4%) patients over a several week
period. Each patient provided informed consent prior to
participation in the study.
The community paramedics have undergone a 6-week
education program designed and provided by Centennial
College, expanding their scope of care for this patient
population and non-emergency practice. The paramedics
have also successfully completed EMR training, data entry
training, and an additional communications course. To
date, 106 patients have had their initial visit with a com-
munity paramedic where consent was reconfirmed and
initial assessment completed and documented using the
electronic interfaces developed specifically for the trial.
There have been no safety concerns, 100% timely oversight
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community paramedic initiated a call to 911 for emer-
gency care.
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